Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RNL-Vascostem in Buerger's Disease
NCT01302015Phase 2Completed
- Sponsor
- R Bio
- Start
- Dec 2007
- Primary completion
- Dec 2013
- Modality
- Mesenchymal Stem Cells, Patient-derived iPSCs, Allogeneic iPSCs
- Countries
- 1
01
Overview
A Phase 2 trial of astrostem in thromboangiitis obliterans (TAO), sponsored by R Bio. Started Dec 2007; status: completed.
02
Drugs
astrostem
03
Conditions
thromboangiitis obliterans (TAO)
Beyond the preview
Go deeper on NCT01302015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01302015.